Skip to main content
. 2022 May 1;226(11):1949–1958. doi: 10.1093/infdis/jiac165

Table 1.

Demographic Characteristics and Clinical Laboratory Findings Among Patients With Dengue and Severe Dengue, Sentinel Enhanced Dengue Surveillance System, Puerto Rico, 2012–2014

Characteristic Total, No. (%) (n = 1089) Severe, No. (%) (n = 281) Nonsevere, No. (%) (n = 808) P Value,a Severe vs Nonsevere
Sex
 Male 579 (53.2) 158 (56.2) 421 (52.1) .26
 Female 510 (46.8) 123 (43.8) 387 (47.9) .26
Age, y, median (range) 15.3 (0–97.1) 16.1 (0.2–82.8) 14.9 (0–97.1) .04
 0–9 274 (25.2) 49 (17.4) 225 (27.8) .001
 10–19 478 (43.9) 155 (55.2) 323 (40.0) .001
 20–29 119 (10.9) 25 (8.9) 94 (11.6) .25
 30–39 59 (5.4) 15 (5.3) 44 (5.4) 1.0
 40–49 47 (4.3) 9 (3.2) 38 (4.7) .37
 50+ 112 (10.3) 28 (10.0) 84 (10.4) .93
Year of recruitment
 2012 418 (42.8) 115 (48.5) 303 (40.9) .05
 2013 455 (46.6) 108 (45.6) 347 (46.9) .78
 2014 104 (10.6) 14 (5.9) 90 (12.2) .01
Days after illness onset, median (range) 3 (0–7.0) 4 (0–7.0) 3 (0–7.0) <.001
 <3 417 (38.3) 63 (22.4) 354 (43.8) <.001
 3–5 592 (54.4) 191 (68.0) 401 (49.6) <.001
 6–7 80 (7.3) 27 (9.6) 53 (6.6) .12
Disposition
 Admitted 483 (44.4) 245 (87.2) 238 (29.5) <.001
 Died 1 (0.1) 0 (0) 1 (0.1) 1.0
 Sent home 602 (55.3) 34 (12.1) 568 (70.3) <.001
 Transferred 3 (0.3) 2 (0.7) 1 (0.1) .34
Duration of hospitalization among those hospitalized n = 483 n = 245 n = 238
 Duration of hospitalization in days, median (range) 3.0 (0–14.0) 3.5 (0–14.0) 3.0 (1.0–10.0) <.001
Secondary DENV infection n = 719 n = 183 n = 536
 No 153 (21.3) 24 (13.1) 129 (24.1)
 Yes 566 (78.7) 159 (86.9) 407 (75.9) .003
Infecting DENV n = 720 n = 176 n = 544
 DENV-1 679 (94.3) 161 (91.5) 518 (95.2) .09
 DENV-2 3 (0.4) 0 (0) 3 (0.6) .75
 DENV-4 38 (5.3) 15 (8.5) 23 (4.2) .04
Laboratory findings
 Highest AST U/L, median (range) 104 (10–8111) 153 (13–8111) 86 (10–909) <.001
  AST <50 U/L 129 (22.8) 49 (19.4) 80 (25.4) .11
  AST 51–500 U/L 388 (68.4) 164 (65.1) 224 (71.1) .15
  AST 501–1000 U/L 38 (6.7) 27 (10.7) 11 (3.5) .001
  AST >1000 U/L 12 (2.1) 12 (4.8) 0 (0) <.001
 Lowest ALT U/L, median (range) 87 (160–7548) 136 (20–7548) 68 (16–968) <.001
  ALT <50 U/L 161 (28.3) 49 (19.4) 112 (35.4) <.001
  ALT 51–500 U/L 364 (64.0) 170 (67.2) 194 (61.4) .18
  ALT 501–1000 U/L 39 (6.9) 29 (11.5) 10 (3.2) <.001
  ALT >1000 U/L 5 (0.9) 5 (2.0) 0 (0) .0396
 Lowest WBC/microL, median (range) 3400 (800–24 000) 2900 (800–19 000) 3700 (900–24 000) <.001
  WBC ≤4000 cells/microL 661 (62.2) 212 (76.5) 449 (57.2) <.001
  WBC 4001–10 000 cells/microL 358 (33.7) 60 (21.7) 298 (38) <.001
  WBC >10 000 cells/microL 43 (4.0) 5 (1.8) 38 (4.8) .04
 Lowest PLT/microL, median (range) 11 4000 (2000–511 000) 62 000 (2000–457 000) 134 000 (3000–511 000) <.001
  PLT < 50 000/microL 158 (14.9) 87 (31.3) 71 (9.1) <.001
  PLT 50 000–100 000/microL 294 (27.7) 119 (42.8) 175 (22.3) <.001
  PLT >100 000/microL 609 (57.4) 72 (25.9) 537 (68.6) <.001
 Thrombocytopenia <100 000 platelets/microL 452 (42.6) 206 (74.1) 246 (31.4) <.001
 Highest hematocrit %, median (range) 41.2 (28.5–57.4) 41.3 (28.9–55.5) 41.0 (28.5–57.4) .95
 Hemoconcentration 60 (5.6) 30 (10.8) 30 (3.8) <.001
 Low albumin g/dL 309 (65.5) 208 (85.6) 101 (44.1) <.001
 Lowest albumin g/dL, median (range) 3.2 (1.9–5.0) 3.1 (1.9–4.1) 3.4 (2.0–5.0) <.001

Data are No. (%) except where indicated.

Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; DENV, dengue virus; PLT, platelets; WBC, white blood cell; U/L, units per litre; microL, microlitre; dL, decilitre; g, grams.

a

Calculated with the Mann-Whitney-Wilcoxon test to compare medians and χ2 test to estimate the difference in proportions.